U.S. Markets open in 7 hrs 26 mins

What’s behind Gemphire Therapeutics’ Stock Price Rise

Daniel Collins
What’s behind Gemphire Therapeutics’ Stock Price Rise

On July 6, Gemphire Therapeutics (GEMP) stock closed at $8.09, ~70% higher than its 52-week low of $4.75 on May 7. After Gemphire announced positive clinical trial results on June 28, its stock price started to rise and closed at $5.24, and on June 29, it rose ~94.47% to $10.19.